Sevil OKAN, Ayla Çağlıyan TÜRK, Füsun ŞAHİN, Ahmet MUSMUL, Ferit Kerim KÜÇÜKLER, Sumru ÖZEL, Murat BAĞLICAKOĞLU

BOZULMUŞ AÇLIK GLUKOZU OLAN KADIN HASTALARDA FİBROMİYALJİ SIKLIĞI: KESİTSEL ÇALIŞMA

Amaç: Bozulmuş açlık glukozu olan kadınlarda fibromiyalji sıklığını değerlendirmek. Materyal ve Metot: Dahiliye polikliniğine nonspesifik nedenlerle başvuran kadınlar arasından, rutin muayenesinde açlık kan şekeri düzeyi 100-126 olanlar çalışma grubunu (Grup 1) ve açlık kan şekeri değeri 100'den küçük olanlar kontrol grubunu oluşturdu (Grup 2). Bozulmuş açlık glukozu (BAG) olan hastalara (Grup 1) oral glukoz tolerans testi (OGTT) yaptırıldı ve 2. Saat OGTT değeri 140’ın altında olan hastalar çalışmaya dahil edildi. Fibromiyalji Etki Anketi (FIQ) kullanılarak fonksiyonel durum değerlendirildi. Fibromiyalji tanısı için ağrı yerleşim skoru (AYS) ve semptom etkilenme skorlaması (SES) değerlendirildi. Bulgular: Ortalama yaş Grup 1'de 48.99 ± 7.50 (n = 73) ve Grup 2'de 47.84 ± 7.92 idi (n = 73), aralarında anlamlı fark yoktu. Ortalama VKİ (vücut kitle indeksi) Grup 1'de 30.41 ± 5.01, Grup 2'de 28.00 ± 4.61 idi, aradaki fark anlamlıydı (p

THE FREQUENCY OF FIBROMYALGIA IN FEMALE PATIENTS WITH IMPAIRED FASTING BLOOD GLUCOSE: CROSSSECTIONAL STUDY

Objectives: To assess the frequency of fibromyalgia among women with impaired fasting glucose.Materials and Methods: The sample was selected from the female patients who applied to the InternalMedicine clinic and whose fasting blood glucose level were 100-126 in their routine examination (Group1) andpatients whose fasting blood glucose were less than 100 constituted the control group (Group2). Oral glucosetolerance test (OGTT) has been applied to patients with impaired fasting glucose (IFG) and whose 2nd hourOGTT levels were under 140 has been included. Functional status was assessed by using the FibromyalgiaImpact Questionnaire (FIQ). Pain Location Inventory (PLI), and Symptom Impact Questionnaire (SIQR) wereevaluated for the diagnosis of fibromyalgia.Results: Mean age was 48.99±7.50 in Group1 (n=73) and 47.84±7.92 in Group2 (n=73) with no significantdifference between them. Mean BMI (body mass index) was 30.41±5.01 in Group1 and 28.00±4.61in Group2,this difference was significant (p

PDF

___

1. Moyano S, Kilstein JG, Miguel CA. New Diagnostic Criteria for Fibromyalgia: Here to Stay? Reumatol Clin 2015;11(4):210-4
2. Chinn S, Caldwell W, Gritsenko K. Fibromyalgia Pathogenesis and Treatment Options Update. Curr Pain Headache Rep 2016;20(4):25.
3. Fava A, Plastino M, Cristiano D, Spano A, Cristofaro S, Opipari C et al. Insulin resistance possible risk factor for cognitive impairment in fibromialgic patients. Metab Brain Dis 2013;28(4):619-27
4. Okifuji A, Bradshaw DH, Olson C. Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions. Clin Reumatol 2009;28(4):475-8
5. Yanmaz MN, Mert M, Korkmaz M. The prevalence of fibromyalgia syndrome in a group of patients with diabetes mellitus. Rheumatol Int 2012;32(4):871-4
6. Loevinger BL, Muller D, Alonso C, Coe CL. Metabolic Syndrome in women with chronic pain. Metabolism 2007;56(1):87-93
7. Alberti KGMM, Zimmet P. Classification and diagnosis of diabetes mellitus. In: Wass John AH, Stewart PM, Amiel SA, Davies MJ (ed.). Oxford textbook of endocrinology and diabetes, Oxford University Press, 2nd ed. 2011; 1703-2160
8. Tishler M, Smorodin T, Vazina-Amit M, Ramot Y, Koffler M, Fishel B. Fibromyalgia in diabetes mellitus. Rheumatol Int 2003;23(4):171-3.
9. Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM. Kinin B1 receptors: key Gprotein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol 2004;143(7):803-18.
10. Couture R, Girolami JP. Putative roles of kinin receptors in the therapeutic effects of angiotensin 1- converting enzyme inhibitors in diabetes mellitus. Eur J Pharmacol 2004;500(1 -3):467-85.
11. Nichols GA, Hillier TA, Brown JB. Progression from newly acquired impaired fasting glucose to type 2 diabetes. Diabetes Care 2007;30(2):228–33.
12. Solomon TP, Haus JM, Kelly KR, Cook MD, Filion J, Rocco M, et al. A low–glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia and glucosedependent insulinotropic polypeptide responses in obese, prediabetic humans. Am J Clin Nutr 2010;92(6):1359–68.
13. World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva, Switzerland: WHO; 2006;Issue 4:21-8
14. Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R, et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res (Hoboken) 2014;66(9):1364-73
15. Rooks DS. Talking to patients with fibromyalgia about physical activity and exercise. Current Opinion in Rheumatology 2008;20:208–12
16. Burckhardt CS, Clark Sr, Bennet RM. The fibromiyalgia impact questionnaire: development and validation. J Rheumatol 1991;18(5):728-33.
17. Sarmer S, Ergin S, Yavuzer G. The validity and realibility of the Turkish version of the Fibromyalgia impact questionnaire. Rheumatol Int 2000;20(1):9-12.
18. Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA, et al. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun 2004; 18(4):314-25.
19. Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J 2012; 12(1):5-18.
20. Bagis S, Tamer L, Sahin G, Bilgin R, Güler H, Ercan B, et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 2005;25(3):188-90
21. Wolak T, Weitzman S, Harman-Boehm I, Friger M, Sukenik S. Prevalence of fibromyalgia in type 2 diabetes mellitus. Harefuah. 2001;140(11):1006-9.
22. Krein SL, Heisler M, Piete JD, Makki F, Kerr E. The effects of chronic pain on diabetes patients’ self- management. Diabetes Care 2005;28(1):65-70.
23. Mäntyselkä P, Miettola J, Niskanen L, Kumpusalo E. Chronic pain, impaired glucose tolerance and diabetes: A community-based study. Pain 2008;137(1):34-40.